Skip to ContentSkip to Navigation
How to find us B. Gareb, MSc


Targeting the ileo-colonic region in inflammatory bowel disease

Review: Local Tumor Necrosis Factor-alpha Inhibition in Inflammatory Bowel Disease

Development of novel zero-order release budesonide tablets for the treatment of ileo-colonic inflammatory bowel disease and comparison with formulations currently used in clinical practice

Towards the Oral Treatment of Ileo-Colonic Inflammatory Bowel Disease with Infliximab Tablets: Development and Validation of the Production Process

Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease

Read more